Built by People Who’ve Led Healthcare Operations — Not Just Studied Them

Coreo was founded on the belief that cancer care shouldn’t depend on whether the right person happens to see the right information at the right time—and follows through. Here’s who’s building it, and why.

Our Motivation

My career spans decades as a healthcare administrator, leading care delivery systems and repeatedly confronting the same problem from the inside: care plans that were documented but broke down in execution. No amount of professional experience prepared me for encountering that breakdown personally — when failed communication and follow-through in cancer care affected my own family.

A nurse holding a patient’s hands

That experience is the reason Coreo exists. Health systems don’t lack good intentions or clinical expertise. They lack infrastructure that makes sure a care plan’s next step has a clear owner and a visible deadline — regardless of how many people and systems that step passes through.

I’ve shared this experience in speaking engagements across the country, and it consistently resonates with clinicians and administrators who’ve seen the same gaps from their own vantage point. Coreo is my attempt to close that gap — not by replacing the systems and people already doing this work, but by giving them the visibility they’ve never had.

Christie L. Clipper, DHA

Founder & CEO

Our Mission

Coreo’s mission is to make sure cancer care plans are followed through on — not just documented. We do this by giving care teams a shared, real-time view of where a patient’s care stands, who owns the next step, and what may be at risk of falling through, without adding another disconnected system to an already complex workflow.

We believe no patient’s outcome should depend on which team member happened to catch a missed step. That’s not a technology problem alone — it’s an infrastructure problem, and it’s the one Coreo was built to solve.

Leadership Team

Christie L. Clipper, DHA

Christie L. Clipper, DHA

Founder & CEO

Dr. Christie L. Clipper is a healthcare entrepreneur and operating executive with nearly three decades of experience building, scaling, and transforming regulated care delivery organizations. Her career has centered on turning complex healthcare concepts into functioning, compliant, and revenue-generating operations — experience that directly informs how she is building Coreo for enterprise adoption.

Earlier in her career, Dr. Clipper launched and grew multiple healthcare organizations, including outpatient rehabilitation facilities, home care agencies, independent diagnostic testing facilities, and physician and rehabilitation service models serving underserved communities. Her work encompassed operating model design, staffing, workflow development, payer certification, accreditation, compliance readiness, and launch. One rehabilitation model grew into a multi-facility footprint across Southeastern Michigan, including three outpatient sites paired with in-home services for homebound patients.

Within large health systems, Dr. Clipper has held operating leadership responsibility for multimillion-dollar budgets, service-line performance, and care delivery transformation. At Henry Ford Health, she led ambulatory and inpatient operations for the Division of Endocrinology, Diabetes and Bone & Mineral Disorders and helped advance shared medical appointments and telemedicine from pilot programs toward broader health system adoption.

From 2020 to 2025, Dr. Clipper served as Director of the Center for Personalized Health Care at Duke University Medical Center, where she oversaw strategy, operations, finance, research, and digital transformation. She led the transition of Duke’s personalized care model to a virtual platform and worked directly with Duke’s Office of Technology and Commercialization to evaluate commercialization and spinout pathways for care delivery innovations developed by the Center.

Her research spans patient-provider communication, care delivery innovation, and the use of artificial intelligence in oncology. Her peer-reviewed work includes a study published in JMIR Perioperative Medicine examining physician perspectives on AI-based patient resources in cancer surgery.

Coreo is also grounded in deeply personal experience. After witnessing the consequences of communication breakdowns during her mother’s cancer care, Dr. Clipper came to understand the human cost of fragmented coordination not only as a healthcare executive, but as a daughter and caregiver. That experience transformed a longstanding professional concern into a personal commitment: to build a system that creates value for patients, care teams, and payers by helping clinically sound care be reliably carried through.

This combination of entrepreneurial execution, health system leadership, commercialization experience, research, and firsthand understanding of the consequences of fragmented cancer care positions Dr. Clipper to build Coreo not simply as a clinical concept or standalone technology, but as scalable infrastructure designed to make coordinated care more reliable, accountable, and human.

Ted Dacko

Ted Dacko

Business Advisor

Ted has over 47 years of experience in executive-level management and leadership, including sales, marketing, M&A, and CEO roles principally in healthcare applications and solutions. As a seven-time CEO, he grew HealthMedia from concept to a $185 million exit to Johnson & Johnson, and has worked with early-stage companies including Groundspeed Technologies, Workit Health, and MyStrength.

Nancy Benovich Gilby

Nancy Benovich Gilby

Advisor, Software Development & Product Adoption

Nancy is a veteran technology executive and startup builder with 30+ years of experience founding or leading products at 14 high-tech ventures — raising 12 funding rounds and delivering eight strategic exits, including Component Software (folded into Sun to become Java), Firefly (acquired by Microsoft), Wildfire (acquired by Orange), and On Technology’s Meeting Maker (acquired by Symantec). As VP of Engineering for Asurion Mobile, she scaled cloud-based mobile services to over 100 million users. She holds two patents and is the subject of three Harvard Business School case studies.

Steve Schwartz

Steve Schwartz

Acting CTO, Alfa Jango

Steve is a serial tech entrepreneur and CTO with nearly two decades of experience founding and scaling software startups, including Genomenon — an AI-powered genomics company acquired by Boston Genetics in 2023 — and Carcode, acquired by Edmunds.com. He has built high-impact technical teams and open-source software with hundreds of millions of downloads, and advises founders and invests in early-stage startups.

John Hoinville

John Hoinville

Product & Operations Lead, Alfa Jango

John is a technology leader with deep expertise in product development, project management, and business analysis, spanning Fortune 10 companies to early-stage startups, with a track record of mentoring startups from ideation through MVP.

John Vander Meulen

John Vander Meulen

Sales Executive

John brings over 30 years of experience in sales, operations, and professional services, including more than 25 years focused on healthcare technology and enterprise software. He has held executive leadership roles at organizations including Johnson & Johnson, EDS, Chrysler, and Compuware Corporation.

Medical Advisory Board

Kevin C. Oeffinger, MD, FASCO

Kevin C. Oeffinger, MD, FASCO

  • Founding Director, Duke Cancer Institute Center for Onco-Primary Care
  • Director, DCI Supportive Care & Survivorship Center
  • Professor of Medicine, Duke University Medical Center
Thomas LeBlanc, MD

Thomas LeBlanc, MD

  • Chief Patient Experience & Safety Officer, Duke Cancer Institute
  • Founding Director, Duke Cancer Patient Experience Research Program
  • Associate Professor of Medicine & Population Health Sciences, Duke University

Want to Learn More About Coreo?

See How Coreo Works Talk to Our Team